Join us at Endpoints 11 in September No images? Click here The top 11 biotechs building for today's market reality The biotech landscape is evolving, and recognizing the companies positioned to navigate today's challenges requires a sharper lens. Endpoints News is heading to Boston to unveil the 2025 Endpoints 11 — a curated selection of biotech startups and founders who are building with discipline and strategic focus in an increasingly demanding market. Early bird rate — save $150 — limited in-person tickets Join us for an evening where you'll hear directly from the people behind these companies, understand their strategies, and connect with the investors and industry leaders who are betting on biotech's next phase. ![]() This isn't about flashy promises or easy wins. It's about identifying the teams, science, and approaches that show real potential to create value when capital is scarce and expectations are high. Meet the future of biotech — join us. Save $150 with Early Bird — Limited in-person tickets |